title: Role of phospholipase A2 in cholesterol gallstone formation is associated with biliary phospholipid species selection at the site of hepatic excretion: indirect evidence.
abstract: Phospholipase A2 plays a role in cholesterol gallstone development by hydrolyzing bile phospholipids into lysolecithin and free fatty acids. Lysolecithin and polyunsaturated free fatty acids are known to stimulate the synthesis and/or secretion of gallbladder mucin via a prostanoid pathway, leading to enhancing cholesterol crystal nucleation and growth, and therefore, the action of phospholipase A2 is associated, in part, with bile phospholipid fatty acid. To clarify this hypothesis, we evaluated the effect on bile lipid metastability in vitro of replacing phospholipids with lysolecithin and various free fatty acids. Supersaturated model biles were created with an identical composition (cholesterol saturation index, 1.8; egg yolk lecithin, 34 mM; taurocholate, 120 mM; cholesterol, 25 mM) except for 5%, 10%, or 20% replacement of egg yolk lecithin with a combination of palmitoyl-lysolecithin and a free fatty acid (palmitate, stearate, oleate, linoleate, or arachidonate), followed by time-sequentially monitoring of vesicles and cholesterol crystals using spectrophotometer and video-enhanced differential contrast microscopy. Replacement with hydrophilic fatty acids (linoleate and arachidonate) reduced vesicle formation and promoted cholesterol crystallization, whereas an enhanced cholesterol-holding capacity was evident after replacement with hydrophobic fatty acids (palmitate and stearate). These results indicate that the effect of phospholipase A2 on bile lithogenecity is modulated by the fatty acid species in bile phospholipids, and therefore, that the role of phospholipase A2 in cholesterol gallstone formation is dependent, in part, on biliary phospholipid species selection at the site of hepatic excretion.
authors.affiliation: First Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Hattori
authors.forename: S
authors.initials: S
authors.lastname: Tazuma
authors.forename: G
authors.initials: G
authors.lastname: Yamashita
authors.forename: H
authors.initials: H
authors.lastname: Ochi
authors.forename: Y
authors.initials: Y
authors.lastname: Sunami
authors.forename: T
authors.initials: T
authors.lastname: Nishioka
authors.forename: H
authors.initials: H
authors.lastname: Hyogo
authors.forename: S
authors.initials: S
authors.lastname: Yasumiba
authors.forename: T
authors.initials: T
authors.lastname: Kajihara
authors.forename: K
authors.initials: K
authors.lastname: Nakai
authors.forename: K
authors.initials: K
authors.lastname: Tsuboi
authors.forename: Y
authors.initials: Y
authors.lastname: Asamoto
authors.forename: M
authors.initials: M
authors.lastname: Sakomoto
authors.forename: G
authors.initials: G
authors.lastname: Kajiyama
mesh_terms: D001646:Bile / Q000737:chemistry / Q000378:metabolism*; D002769:Cholelithiasis / Q000209:etiology*; D002784:Cholesterol / Q000737:chemistry / Q000502:physiology*; D003460:Crystallization; D003461:Crystallography; D004531:Eggs / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000378:metabolism*; D008853:Microscopy / Q000379:methods; D010713:Phosphatidylcholines / Q000494:pharmacology; D010741:Phospholipases A / Q000502:physiology*; D054467:Phospholipases A2; D010743:Phospholipids / Q000145:classification / Q000502:physiology*; D011506:Proteins / Q000032:analysis; D013690:Television
chemical_list: D008055:Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D011506:Proteins; D002784:Cholesterol; D010741:Phospholipases A; D054467:Phospholipases A2